INTERNATIONAL PATENT: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HEALTHCARE-ASSOCIATED CANDIDA AURIS INFECTIONS WITH DUAL ANTIGEN VACCINE"

GENEVA, Dec. 9 -- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER (1124 West Carson StreetTorrance, California 90502-2064) filed a patent application (PCT/IB2025/055573) for "COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HEALTHCARE-ASSOCIATED CANDIDA AURIS INFECTIONS WITH DUAL ANTIGEN VACCINE" on May 29, 2025. With publication no. WO/2025/248488, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IBRAHIM, Ashraf S. (1124 West Carson StreetTorrance, California 90502-2064), SINGH, Shakti (112...